Tag Archives: Japan

BASF’s Optical Film Enhances Anti-Glare Features in Panasonic’s “SHIYUE” Study Luminaire

(IN BRIEF) BASF’s NovaFlex GlareControl optical film has been incorporated into Panasonic’s “SHIYUE” study luminaire, achieving the highest performance level for anti-glare properties as set by the China Quality Certification Center. This partnership highlights BASF’s entry into the Asian market … Read the full press release

Deutsche Telekom Strengthens Majority Stake in T-Mobile US Through SoftBank Agreement

(IN BRIEF) Deutsche Telekom has announced its acquisition of approximately 6.7 million additional shares in its subsidiary, T-Mobile US (TM US), through a strategic agreement with SoftBank from Japan. This move comes as Deutsche Telekom exercises call options on TM … Read the full press release

Japanese Consortium Invests USD$100m in Airbus Subsidiary AALTO to Propel HAPS Commercialization

(IN BRIEF) In a strategic move set to redefine connectivity and earth observation services in Japan and across Asia, a consortium of leading Japanese businesses and banks, spearheaded by NTT DOCOMO, Inc. and Space Compass Corporation, commits a substantial USD$100 … Read the full press release

Neste, Marubeni, and Resonac Collaborate for Renewable Olefins Production

(IN BRIEF) Neste, Marubeni Corporation, and Resonac Corporation have formed a partnership to facilitate the production of renewable olefins and derivatives. Through this agreement, Neste’s renewable feedstock, Neste RE™, will be utilized by Resonac at its Oita Complex in Japan, … Read the full press release

Accenture to Bolster Digital Transformation with OPENSTREAM HOLDINGS Acquisition

(IN BRIEF) Accenture (NYSE: ACN) has announced its acquisition of OPENSTREAM HOLDINGS and its subsidiaries, Open Stream and Neutral, marking a significant move to enhance its digital engineering and manufacturing capabilities. The acquisition, with undisclosed terms, is set to bring … Read the full press release

Cotti Coffee Chooses Adyen’s Platform for Global Expansion and Enhanced Customer Experience

(IN BRIEF) Adyen, a leading financial technology platform, has partnered with Cotti Coffee to support the global coffee chain’s expansion into new international markets including Canada, Australia, Japan, Singapore, and the UAE. This strategic collaboration leverages Adyen’s single-platform solution to … Read the full press release

Accenture Enhances Japanese Presence with CLIMB Acquisition, Bolstering Digital Transformation Capabilities

(IN BRIEF) Accenture has finalized the acquisition of CLIMB, a technology services provider renowned for its system integration and IT infrastructure management expertise, particularly in Gunma Prefecture. This strategic move, initially announced on April 8, 2024, brings approximately 230 professionals, … Read the full press release

Munich Re Revamps Leadership Structure to Strengthen Regional Underwriting in Asia Pacific & Africa

(IN BRIEF) Munich Re announces strategic changes to its leadership structure in Asia Pacific, Middle East & Africa (APAC MEA), aimed at bolstering its in-market Underwriting capabilities and refining its regional divisions. The revised setup will prioritize stronger local Underwriting … Read the full press release

Rheinmetall Secures Major Contract to Introduce Autonomous Ground Vehicles in Japan

(IN BRIEF) Rheinmetall has clinched a significant multimillion-dollar contract from the Japanese Ministry of Defence, paving the way for the introduction of autonomous Unmanned Ground Vehicles (UGVs) in Japan. The contract entails the delivery of Rheinmetall Mission Master SP UGVs … Read the full press release

Accenture to Bolster Technology Expertise with Acquisition of CLIMB in Gunma Prefecture

(IN BRIEF) Accenture, a global technology services provider, has announced its agreement to acquire CLIMB, a technology services provider specializing in system integration and IT infrastructure management primarily in Gunma Prefecture, Japan. This acquisition aims to enhance Accenture’s capabilities in … Read the full press release

Maersk Names Second Methanol-Enabled Vessel ‘Astrid Mærsk’ in Yokohama Ceremony

(IN BRIEF) In Yokohama, Japan, Maersk celebrated the naming ceremony of the “Astrid Mærsk,” the second of its 18 large methanol-enabled vessels, marking a significant step towards its net-zero targets. With Mrs. Liza Uchida, spouse of Nissan CEO Makoto Uchida, … Read the full press release

Panasonic Implements Advanced AI Tire Pressure Monitoring System in TiMO A e-Assisted Bike with STMicroelectronics’ Edge AI Solutions

(IN BRIEF) STMicroelectronics (NYSE: STM) has announced Panasonic Cycle Technology’s adoption of the STM32F3 microcontroller (MCU) and edge AI development tool, STM32Cube.AI, for their TiMO A e-assisted bike. This collaboration introduces an innovative tire pressure monitoring system (TPMS) using advanced … Read the full press release

AstraZeneca and Daiichi Sankyo’s BLA for Datopotamab Deruxtecan Accepted by FDA for Advanced Breast Cancer Treatment

(IN BRIEF) AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been acknowledged by the US FDA for treating adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-negative breast cancer who have received prior systemic … Read the full press release

AstraZeneca and Sanofi’s Beyfortus Receives Approval in Japan for Prophylaxis against Respiratory Syncytial Virus

(IN BRIEF) AstraZeneca and Sanofi celebrate the approval of Beyfortus (nirsevimab) in Japan by the Ministry of Health, Labour, and Welfare for preventing lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in neonates, infants, and children entering … Read the full press release

AstraZeneca’s Truqap Gets Green Light in Japan for Advanced Breast Cancer Treatment

(IN BRIEF) AstraZeneca announces the approval of Truqap (capivasertib) in combination with Faslodex (fulvestrant) by the Japanese Ministry of Health, Labour, and Welfare (MHLW) for treating adult patients with unresectable or recurrent hormone receptor-positive, HER2-negative breast cancer. The approval, based … Read the full press release

Eckert & Ziegler’s GalliaPharm® Generator Powers Groundbreaking Cancer Diagnostic Trial in Japan

(IN BRIEF) Eckert & Ziegler, in collaboration with Novartis Pharma K.K., is expanding Ga-68 labeled diagnostics in Japan through a clinical trial approved by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). Utilizing Eckert & Ziegler’s GalliaPharm® generator, the trial … Read the full press release

Climate Change Report: Urgent Adaptation Measures Needed to Stem Rising Economic Losses, Swiss Re Institute Finds

(IN BRIEF) Swiss Re Institute’s latest analysis reveals that climate change is poised to escalate economic losses globally due to severe weather events. The report highlights the vulnerability of countries like the Philippines and the United States, which face significant … Read the full press release

Heraeus Invests in Sustainable Ammonia Technology with Japanese Startup Tsubame BHB

(IN BRIEF) Heraeus, a technology group based in Hanau, Germany, has made a strategic investment in the Japanese startup Tsubame BHB, marking its commitment to sustainable technologies and expanding its presence in Japan. Tsubame BHB specializes in developing environmentally friendly … Read the full press release

Dupixent® Receives Landmark Approval in Japan for Chronic Spontaneous Urticaria Treatment

(IN BRIEF) Japan’s Ministry of Health, Labor and Welfare (MHLW) has authorized the marketing and manufacturing of Dupixent® (dupilumab) for treating chronic spontaneous urticaria (CSU) in patients aged 12 years and older. This approval marks a significant milestone as Japan … Read the full press release

Acoramidis Shows Positive Results in Japanese Trial for Treating Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

(IN BRIEF) In a Phase III trial conducted in Japan, acoramidis, an investigational treatment for transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), demonstrated promising high-level results consistent with the global BridgeBio Pharma, Inc. ATTRibute-CM Phase III trial. The trial in Japan aimed to … Read the full press release